Comparison of manufacturing techniques for adenovirus production

Cytotechnology

Volumn 30, Issue 1-3, 1999, Pages 169-172

  Iyer, Paddy ^a   Ostrove, Jeffrey M ^a,b   Vacante, Dominick ^a  

^a BioRdiance Corporation   (United States)

^b Neurovir   (Canada)

Author keywords

293 cells; Adenovirus; Bioreactor; Microcarriers; Serum free medium

Indexed keywords

ADENOVIRUS; BIOREACTOR; MICROCARRIER; VECTOR;

EID: 0032899431     PISSN: 09209069     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1008040221630     Document Type: Article

References (6)

1. Crystal R (1995) Transfer of genes to humans early lessons and obstacles to success. Science 270: 404-409.
2. Gamier A, Cote J, Nadeau I, Kamen A and Massie B (1994) Scale-up of the adenovirus expression system for the production of recombinant protein in human 293S cells. Cytotechnol 15: 145-155.
3. Jones N and Shenk T (1979) An adenovirus type 5 early gene function regulates expression of other early viral genes. Proc Natl Acad Sci USA 76: 3665-3669.
4. Nadeau J, Garcier A, Cote J, Massie B, Chavarie C and Kamen A (1996) Improvement of recombinant protein production with the human adenovirus/293S expression system using fed-batch strategies. Biotechnol Bioeng 51: 613-623.
5. Nahapetian A, Thomas J and Thilly W (1986) Optimization of environment for high density vero cell culture. Effect of dissolved oxygen and nutrient supply on cell growth and changes in metabolites. J Cell Sci 81: 65-103.
6. Schmidt N and Emmons R (1989) Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections. (pp 18-21) Sixth Edition, American Public Health Association, Washington, D.C.